BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Calyxt Announces Gerry Nuovo as Senior Vice President of Business Development

  Calyxt, Inc. today announced that Gerry Nuovo has joined Calyxt as Senior Vice President of Business Development.

  February 7, 2022

   · 

  5 min read
• Drug Development

  Nanoscope Therapeutics Announces Completed Enrollment of its Phase 2b Clinical Trial in Blind Patients for Optogenetic Gene Therapy to Restore Vision

  Nanoscope Therapeutics today announced full enrollment of its Phase 2b clinical trial of MCO-010, an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic monotherapy to restore vision in patients with retinitis pigmentosa (RP).

  February 7, 2022

   · 

  2 min read
• BioMidwest

  First Wave BioPharma to Participate in the 2022 BIO CEO & Investor Conference

  First Wave BioPharma, Inc. announced that James Sapirstein, Chairman, President and CEO of First Wave BioPharma, will deliver a virtual presentation at the 2022 BIO CEO & Investor Conference.

  February 7, 2022

   · 

  2 min read
• Business

  Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

  Organogenesis Holdings Inc. today announced that fourth quarter and fiscal year 2021 financial results will be reported after the market closes on Tuesday, March 1st.

  February 7, 2022

   · 

  1 min read
• Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles

  Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping VASOSTRICT®, vasopressin injection, USP, in ready-to-use 100 mL pre-mix bottles.

  February 7, 2022

   · 

  5 min read
• Bio NC

  Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest

  Labcorp, a leading global life sciences company, announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.

  February 7, 2022

   · 

  2 min read
• Drug Development

  Actuate Therapeutics Announces Initiation of a Multicenter Randomized Trial of Elraglusib Plus FOLFIRINOX As First Line Therapy for Advanced Pancreatic Cancer

  Actuate Therapeutics, Inc. today announced the opening of a randomized study of elraglusib (9-ING-41) plus FOLFIRINOX alone or with Losartan for patients with advanced pancreatic cancer in the first-line setting (NCT05077800).

  February 7, 2022

   · 

  4 min read
• BioMidwest

  Abbott Announces World’s First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial

  Abbott’s investigational Aveir™ DR dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

  February 7, 2022

   · 

  5 min read
• Business

  CytomX Therapeutics Announces Promotion of Amy C. Peterson, M.D. to President and Chief Operating Officer

  CytomX Therapeutics, Inc. today announced the promotion of Amy C. Peterson, M.D., to the position of president and chief operating officer, effective immediately.

  February 7, 2022

   · 

  4 min read
• Pharm Country

  Aruvant to Participate in the 2022 BIO CEO & Investor Gene Therapy Panel on February 16, 2022

  Aruvant announced that management will participate in the 2022 BIO CEO & Investor conference taking place at the Marriott Marquis in New York City from February 14 to 15 and virtually through February 17, 2022.

  February 7, 2022

   · 

  2 min read